Louise Chen analyst CANTOR FITZGERALD

Currently out of the existing stock ratings of Louise Chen, 380 are a BUY (88.99%), 43 are a HOLD (10.07%), 4 are a SELL (0.94%).

Louise Chen

Work Performance Price Targets & Ratings Chart

Analyst Louise Chen works at CANTOR FITZGERALD with a stock forecast success ratio of 38.82% fulfilled within 190.34 days on average.

Louise Chen’s has documented 825 price targets and ratings displayed on 56 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on PCVX, Vaxcyte  at 09-May-2024.

Wall Street Analyst Louise Chen

Analyst best performing recommendations are on HZNP (HORIZON PHARMA PLC).
The best stock recommendation documented was for HZNP (HORIZON PHARMA PLC) at 2/27/2019. The price target of $26 was fulfilled within 1 day with a profit of $4.15 (18.99%) receiving and performance score of 189.93.

Average potential price target upside

ACRS Aclaris Therapeutics AGN Allergan plc AMRN Amarin PLC ANIP ANI Pharmaceuticals ARDX Ardelyx ENDP Endo International PLC ETTX Entasis Therapeutics Holdings HGEN Humanigen HZNP Horizon Pharma PLC IMAB I-Mab JNJ Johnson & Johnson LLY Eli Lilly and Company MNK Mallinckrodt plc MYL Viatris PFE Pfizer PRGO Perrigo Company PLC SOLY Soliton TEVA Teva Pharma Industries Ltd ADR TXMD TherapeuticsMD ZTS Zoetis EFTR Effector Therapeutics EOLS Evolus MRK Merck mpany CRXT Clarus Therapeutics Holdings OSMT Osmotica Pharmaceuticals plc RVNC Revance The CFRX ContraFect Corp TBPH Theravance Biopharma VTRS Viatris ZTO ZTO Express (Cayman) HRTX Heron Therapeuti SPRO Spero Therapeutics MDCO The Medicines Company AERI Aerie Pharmaceuticals . PAHC Phibro Animal Health PCVX Vaxcyte  JAZZ Jazz Pharmaceuticals PLC ARAV Aravive ARDS Aridis Pharmaceuticals CDTX Cidara Therapeutics CUTR Cutera HCM HUTCHMED DRC MESO Mesoblast Ltd OPK Opko Health PRTK Paratek Pharmaceuticals RVLP RVL Pharmaceuticals PLC SCYX Scynexis THTX Theratechnologies . AKRX Akorn ARQT Arcutis Biotherapeutics  ROIV Roivant Sciences Ltd VYNE Vyne Therapeutics AMAM Ambrx Biopharma . American Depositary Shares IMVT Immunovant  ZLAB Zai Lab Ltd NVO Novo Nordisk A/S

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

4 months 7 days ago

0/2 (0%)

$21.59 (291.36%)

Hold

1.5

4 months 8 days ago

0/4 (0%)

$0.49 (48.51%)

Hold

1

$-0.19 (-15.97%)

2

5 months ago

1/4 (25%)

$0.06 (6.38%)

1

Hold

38

6 months 4 days ago

0/7 (0%)

$23.92 (169.89%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Louise Chen is most bullish on?

Potential upside of $115 has been obtained for LLY (ELI LILLY AND COMPANY)

Which stock is Louise Chen is most reserved on?

Potential downside of -$0 has been obtained for SPRO (SPERO THERAPEUTICS)

What Year was the first public recommendation made by Louise Chen?

On 2010

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?